Results 21 to 30 of about 86,826 (247)
Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma ☆
Hematology/Oncology and Stem Cell Therapy, 2020 Tumor lysis syndrome is a potentially lethal complication of chemotherapy, usually associated with aggressive hematologic malignancies. We describe the case of a young patient with metastatic hepatocellular cancer who developed rapid and fatal tumor ...
Sardar Zakariya Imam +2 more
doaj +1 more source
Journal of Cancer Research and Practice, 2016 Tumor lysis syndrome in solid tumors is a rare occurrence, with a poor prognosis. We present the case of a patient of recurrent colon cancer who received chemotherapy with FOLFOX regimen (lencovorin, fluorouracil, and oxaliplatin) with subsequent tumor ...
Ruo-Han Tseng +4 more
doaj +1 more source
Case Reports in Gastroenterology, 2020 Tumor lysis syndrome (TLS) is a potentially life-threatening complication of chemotherapy. It usually occurs in rapidly proliferating hematological malignancies. TLS is deemed spontaneous (STLS) when it occurs prior to any cytotoxic or definite treatment.
Inna Shaforostova +4 more
doaj +1 more source
Acute tumor lysis syndrome after proximal splenic artery embolization
Radiology Case Reports, 2016 Preoperative splenic artery embolization for massive splenomegaly has been shown to reduce intraoperative hemorrhage during splenectomy. We describe a case of tumor lysis syndrome after proximal splenic artery embolization in a patient with advanced ...
Jason T. Salsamendi +4 more
doaj +1 more source
Spontaneous Tumor Lysis Syndrome
Journal of Investigative Medicine High Impact Case Reports, 2015 Tumor lysis syndrome (TLS) is a known complication of malignancy and its treatment. The incidence varies on malignancy type, but is most common with hematologic neoplasms during cytotoxic treatment. Spontaneous TLS is thought to be rare.
Alicia C. Weeks MD +1 more
doaj +1 more source
Hematological malignancies presenting as spontaneous tumor lysis syndrome: A case series
Journal of Family Medicine and Primary Care, 2018 Tumor lysis syndrome is an oncological emergency caused by massive tumor lysis resulting in a constellation of metabolic abnormalities. It is observed most frequently in patients with high-grade hematological malignancies undergoing treatment.
Shehla Basheer Kollathodi +3 more
doaj +1 more source
JAAPA, 2021 ABSTRACT Tumor lysis syndrome (TLS) is one of the most common oncologic emergencies, occurring when tumor cell contents are rapidly released into the bloodstream. This release of cellular contents, including uric acid, phosphate, and potassium, can rapidly overwhelm the body's homeostasis mechanisms, leading to renal failure, seizures ...
openaire +3 more sources
Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma
Autopsy and Case Reports, 2021 Tumor lysis syndrome is a well-characterized and potentially deadly complication of spontaneous or treatment-related tumor destruction, and it is most commonly associated with hematologic malignancies.
Robin Moiseff +2 more
doaj
International Journal of Gerontology, 2014 Tumor lysis syndrome (TLS) is rarely induces after Transarterial chemoembolization for hepatocellular carcinoma. We present a patient with a large hepatocellular carcinoma who received twice transarterial embolization (TAE).
Hsaing-Hung Lin +4 more
doaj +1 more source
Tumor lysis syndrome with hepatic failure- A rare presentation of undiagnosed metastatic melanoma
JEM Reports, 2023 Background: Tumor Lysis syndrome is an oncologic emergency with high morbidity and mortality. Recognition of the constellation of hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia is critical to identifying the disease in time to intervene.
Nicholas Cochran-Caggiano +2 more
doaj +1 more source